epitol
Generic: carbamazepine
Labeler: teva pharmaceuticals usa, inc.Drug Facts
Product Profile
Brand Name
epitol
Generic Name
carbamazepine
Labeler
teva pharmaceuticals usa, inc.
Dosage Form
TABLET
Routes
Active Ingredients
carbamazepine 200 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
0093-0090
Product ID
0093-0090_5c31da75-fc21-4ab2-9487-64169767ebd0
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA070541
Marketing Start
1990-09-30
Marketing End
2026-07-31
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
00930090
Hyphenated Format
0093-0090
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
epitol (source: ndc)
Generic Name
carbamazepine (source: ndc)
Application Number
ANDA070541 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/1
Packaging
- 100 TABLET in 1 BOTTLE (0093-0090-01)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "5c31da75-fc21-4ab2-9487-64169767ebd0", "openfda": {"nui": ["N0000008486", "N0000175751", "N0000185506", "N0000191266", "N0000187064", "N0000185507", "N0000185607"], "unii": ["33CM23913M"], "rxcui": ["211817", "308979"], "spl_set_id": ["32bbe864-7374-44da-8c6e-e733f0648243"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Mood Stabilizer [EPC]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0093-0090-01)", "package_ndc": "0093-0090-01", "marketing_end_date": "20260731", "marketing_start_date": "19900930"}], "brand_name": "Epitol", "product_id": "0093-0090_5c31da75-fc21-4ab2-9487-64169767ebd0", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "0093-0090", "generic_name": "Carbamazepine", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Epitol", "active_ingredients": [{"name": "CARBAMAZEPINE", "strength": "200 mg/1"}], "application_number": "ANDA070541", "marketing_category": "ANDA", "marketing_end_date": "20260731", "marketing_start_date": "19900930"}